Global Biomarkers Market – Industry Trends and Forecast to 2024 | Data Bridge Market Research - Data Bridge Market Research

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email

Global Biomarkers Market – Industry Trends and Forecast to 2024

Reports

Global Biomarkers Market, By Product Type (Consumables, Services, Softwares), By Technology (Efficacy, Safety, Validation), Application (Diagnostics, Drug Discovery, Personalized Medicine, Disease Risk Assessment), Indication (Cardiovascular, Immunological) By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

$4,200.00
Clear selection
Want create site? Find Free WordPress Themes and plugins.

The Global Biomarkers Market has accounted to USD 31.4 billion in 2016, growing at a CAGR of 12.2% from 2017 to 2024, and is expected to reach USD 78.9 billion by 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Biomarkers are substances or activities that serve as markers of a specific biological activity. Biomarkers are extensively used in research and diagnostic applications. In addition to this, they are also used in the development of new drug therapies through the discovery of new target drugs. Factors such as increasing healthcare expenditure, increase in R&D funding, rising utility of biomarkers for diagnostic purposes, growing number of CROs, low-cost for conducting clinical trials in developing countries, and new initiatives for biomarker research are driving the growth of the biomarkers market. On the other hand, high capital investments and high cost-to-benefit ratio; regulatory and reimbursement challenges; and high cost of testing, sample collection, and storage are the major factors restraining the growth of this market.

The Global Biomarkers Market is segmented on the basis of Product type, technology, applications, and indications.

On the basis of product type, the biomarkers market is segmented into consumables, services, and software. In 2016, the consumables product segment is expected to account for the largest share of the global biomarkers market. The large share of this segment can primarily be attributed to the increasing use of kit-based products for the testing of biomarkers and higher frequency of purchase of consumables as compared to other product segments.

On the basis of technology, the biomarkers market is categorized into safety biomarkers, efficacy biomarkers, and validation biomarkers. In 2016, the safety biomarkers segment is expected to account for the largest share of the global biomarkers market. Safety biomarkers are primarily used in trial phases 1 and 2. They enable the identification of toxicity in candidate drug molecules. Increasing research and development activities in pharmaceutical sector, to identify and validate new candidate therapeutic products is driving the demand for this market segment.

On the basis of applications, the biomarkers market is further segmented into diagnostics development, drug discovery and development, personalized medicine, disease-risk assessment, and other applications. In 2016, the diagnostics development segment is expected to account for the largest share of the global biomarkers market. Biomarkers play a significant role in the diagnosis of various diseases. Thus diagnostics development has major biomarker application compared to other applications due to increasing healthcare expenditure, which is improving access to new and high-quality diagnostics, and aiding growth of the diagnostics applications segment.

On the basis of indications, the biomarkers market is segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases. In 2016, the cancer disease indication segment is expected to account for the largest share of the global biomarkers market. Cancer biomarkers are extensively used in diagnostics, asses cancer progression, prognosis, and to devise treatment plans. They are also used in companion diagnostics products. Increasing incidence of cancer is driving the growth of this segment of the biomarkers market.

Based on geography the global biomarkers market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2016, North America is expected to dominate the market with a share of 35.6%, growing at a CAGR of 10.7% in the forecast period 2017 to 2024. The dominance of North America is owing to high incidence of cardiovascular diseases, coupled with favorable reimbursement scenarios and highest treatment success rate.

The biomarkers market is highly consolidated with few major companies having a large proportion of the market share. The key industry players in the global biomarkers market are QIAGEN N.V, PerkinElmer, Inc, Merck & Co, Inc. Bio-Rad Laboratories, Enzo Biochem, Inc., EKF Diagnostics Holdings, plc, Meso Scale Diagnostics, LLC, Singulex, Inc., Cisbio Bioassays, Biosims Technologies, and Signosis, Inc.

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Choose Licence Type

Enterprise, Single User

Want create site? Find Free WordPress Themes and plugins.

1.INTRODUCTION

1.1.OVERVIEW OF THE GLOBAL BIOMARKERS MARKET

1.2.MARKET SEGMENTATION & COVERAGE

1.2.1.CURRENCY AND PRICING

1.2.2.LIMITATION

1.2.3.STAKEHOLDERS

2.RESEARCH METHODOLOGY

2.1.KEY TAKEAWAYS

2.2.ARRIVING AT THE GLOBAL BIOMARKERS MARKET SIZE

2.2.1.MARKET CRACKDOWN APPROACH

2.2.2.COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3.DATA TRIANGULATION

2.2.4.KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5.PRODUCT PIPELINE ANALYSIS

2.2.6.PORTER’S FIVE FORCES MATRIX

2.3.GLOBAL BIOMARKERS MARKET: RESEARCH SNAPSHOT

2.4.ASSUMPTIONS

3.MARKET LANDSCAPE SUMMARY

4.PREMIUM INSIGHTS

4.1.OVERVIEW

4.2.GLOBAL BIOMARKERS MARKET: KEY PRIMARY INSIGHTS

4.3.MARKET OVERVIEW

4.3.1.DRIVERS

4.3.1.1.INCREASING HEALTHCARE EXPENDITURE

4.3.1.2.NON-INVASIVE

4.3.1.3.LOW-COST FOR CONDUCTING CLINICAL TRIALS

4.3.1.4.GROWING NUMBER OF CROs

4.3.2.RESTRAINTS

4.3.3.OPPURTUNITIES

4.3.4.THREATS

4.4.KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5.EXECUTIVE SUMMARY

6.BIOMARKERS MARKET, BY PRODUCT TYPE

6.1.OVERVIEW

6.2.CONSUMABLES,

6.3.SERVICES,

6.4.SOFTWARE,

7.BIOMARKERS MARKET, BY TECHNOLOGY

7.1.OVERVIEW

7.2.SAFETY BIOMARKERS

7.3.EFFICACY BIOMARKERS

7.4.VALIDATION BIOMARKERS

8.BIOMARKERS MARKET, BY APPLICATION

8.1.    OVERVIEW

8.2.    DIAGNOSTICS DEVELOPMENT

8.3.    DRUG DISCOVERY AND DEVELOPMENT

8.4.    PERSONALIZED MEDICINE

8.5     DISEASE-RISK ASSESSMENT

8.6.    OTHERS

9.BIOMARKERS MARKET, BY INDICATION

9.1.OVERVIEW

9.2.CANCER

9.3.CARDIOVASCULAR DISORDERS

9.4.NEUROLOGICAL DISORDERS

9.5.IMMUNOLOGICAL DISORDERS

9.6.OTHER DISEASES

10.BIOMARKERS MARKET, BY GEOGRAPHY

10.1.COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

10.1.1.NORTH AMERICA

10.1.1.1.U.S.

10.1.1.2.CANADA

10.1.1.3.MEXICO

10.1.2.EUROPE

10.1.2.1.GERMANY

10.1.2.2.FRANCE

10.1.2.3.U.K.

10.1.2.4.ITALY

10.1.2.5.SPAIN

10.1.2.6.RUSSIA

10.1.2.7.TURKEY

10.1.2.8.BELGIUM

10.1.2.9.NETHERLANDS

10.1.2.10.SWITZERLAND

10.1.2.11.REST OF EUROPE

10.1.3.ASIA-PACIFIC (APAC)

10.1.3.1.JAPAN

10.1.3.2.CHINA

10.1.3.3.SOUTH KOREA

10.1.3.4.INDIA

10.1.3.5.AUSTRALIA

10.1.3.6.SINGAPORE

10.1.3.7.THAILAND

10.1.3.8.MALAYSIA

10.1.3.9.INDONESIA

10.1.3.10.PHILIPPINES

10.1.3.11.REST OF APAC

10.1.4.LATIN AMERICA

10.1.4.1.BRAZIL

10.1.4.2.REST OF LATIN AMERICA

10.1.5.MIDDLE EAST AND AFRICA

10.1.5.1.SOUTH AFRICA

10.1.5.2.REST OF MIDDLE EAST AND AFRICA

10.2.KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11.BIOMARKERS MARKET: COMPETITIVE LANDSCAPE

11.1.GLOBAL BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.2.U.S. BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.3.EUROPE BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.4.APAC BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.5.SOUTH AMERICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.6.MIDDLE EAST AND AFRICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.7.MERGERS & ACQUISITIONS

11.8.NEW PRODUCT DEVELOPMENT & APPROVALS

11.9.EXPANSIONS

11.10.REGULATORY CHANGES

11.11.PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12.BIOMARKERS MARKET, COMPANY PROFILES

12.1.QIAGEN N.V

12.1.1.COMPANY OVERVIEW

12.1.2.SWOT ANALYSIS

12.1.3.REVENUE ANALYSIS

12.1.4.PRODUCT PORTFOLIO

12.1.5.RECENT DEVELOPEMENTS

12.1.6.DATA BRIDGE ANALYSIS

12.2.PERKINELMER, INC

12.2.1.COMPANY OVERVIEW

12.2.2.SWOT ANALYSIS

12.2.3.REVENUE ANALYSIS

12.2.4.PRODUCT PORTFOLIO

12.2.5.RECENT DEVELOPEMENTS

12.2.6.DATA BRIDGE ANALYSIS

12.3.MERCK & CO, INC.

12.3.1.COMPANY OVERVIEW

12.3.2.SWOT ANALYSIS

12.3.3.REVENUE ANALYSIS

12.3.4.PRODUCT PORTFOLIO

12.3.5.RECENT DEVELOPEMENTS

12.3.6.DATA BRIDGE ANALYSIS

12.4.BIO-RAD LABORATORIES

12.4.1.COMPANY OVERVIEW

12.4.2.SWOT ANALYSIS

12.4.3.REVENUE ANALYSIS

12.4.4.PRODUCT PORTFOLIO

12.4.5.RECENT DEVELOPEMENTS

12.4.6.DATA BRIDGE ANALYSIS

12.5.ENZO BIOCHEM, INC.,

12.5.1.COMPANY OVERVIEW

12.5.2.SWOT ANALYSIS

12.5.3.REVENUE ANALYSIS

12.5.4.PRODUCT PORTFOLIO

12.5.5.RECENT DEVELOPEMENTS

12.5.6.DATA BRIDGE ANALYSIS

12.6.EKF DIAGNOSTICS HOLDINGS, PLC

12.6.1.COMPANY OVERVIEW

12.6.2.SWOT ANALYSIS

12.6.3.REVENUE ANALYSIS

12.6.4.PRODUCT PORTFOLIO

12.6.5.RECENT DEVELOPEMENTS

12.6.6.DATA BRIDGE ANALYSIS

12.7.MESO SCALE DIAGNOSTICS

12.7.1.COMPANY OVERVIEW

12.7.2.SWOT ANALYSIS

12.7.3.REVENUE ANALYSIS

12.7.4.PRODUCT PORTFOLIO

12.7.5.RECENT DEVELOPEMENTS

12.7.6.DATA BRIDGE ANALYSIS

12.8.LLC, SINGULEX, INC.,

12.8.1.COMPANY OVERVIEW

12.8.2.SWOT ANALYSIS

12.8.3.REVENUE ANALYSIS

12.8.4.PRODUCT PORTFOLIO

12.8.5.RECENT DEVELOPEMENTS

12.8.6.DATA BRIDGE ANALYSIS

12.9.CISBIO BIOASSAYS

12.9.1.COMPANY OVERVIEW

12.9.2.SWOT ANALYSIS

12.9.3.REVENUE ANALYSIS

12.9.4.PRODUCT PORTFOLIO

12.9.5.RECENT DEVELOPEMENTS

12.9.6.DATA BRIDGE ANALYSIS

12.10.BIOSIMS TECHNOLOGIES

12.10.1.COMPANY OVERVIEW

12.10.2.SWOT ANALYSIS

12.10.3.REVENUE ANALYSIS

12.10.4.PRODUCT PORTFOLIO

12.10.5.RECENT DEVELOPEMENTS

12.10.6.DATA BRIDGE ANALYSIS

12.11. SIGNOSIS, INC.

12.11.1.COMPANY OVERVIEW

12.11.2.SWOT ANALYSIS

12.11.3.REVENUE ANALYSIS

12.11.4.PRODUCT PORTFOLIO

12.11.5.RECENT DEVELOPEMENTS

12.11.6.DATA BRIDGE ANALYSIS

13.APPENDIX

14.ABOUT DATA BRIDGE MARKET RESEARCH

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Want create site? Find Free WordPress Themes and plugins.

Available on Request.

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Want create site? Find Free WordPress Themes and plugins.

Available on Request.

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Want create site? Find Free WordPress Themes and plugins.

Please fill in the below form and our sales representatives will get back to you.

Thank You

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
Want create site? Find Free WordPress Themes and plugins.

Thank You

Did you find apk for android? You can find new Free Android Games and apps.
Share this!
`
Show Buttons
Hide Buttons